Dr. Bruce Strober, MD, PhD

Bruce Strober, MD, PhD

Dr. Strober earned both his medical and his doctorate degrees from Columbia University in New York, New York. He subsequently completed his residency in dermatology in the Ronald O. Perelman Department of Dermatology, NYU School of Medicine. He is board certified by the American Board of Dermatology and a Fellow in the American Academy of Dermatology.

Dr. Strober’s research interests include the study of therapeutics, both old and new, for inflammatory skin disease, specifically interventions that help patients with difficult-to-treat psoriasis, atopic dermatitis, and hidradenitis suppurativa. Additional research interests include elucidation of novel features of inflammatory skin disease not previously uncovered and assisting in the clarification of the pathophysiology of inflammatory skin disease. He has served as principal investigator or sub-investigator for numerous multicenter clinical studies.

Dr. Strober is Clinical Professor of Dermatology at Yale University School of Medicine. He is currently the Editor in Chief of the Journal of Psoriasis and Psoriatic Arthritis. Dr. Strober has served as a Section Editor for the British Journal of Dermatology, and an ad hoc reviewer for Journal of the American Academy of Dermatology, JAMA Dermatology, British Journal of Dermatology, and Inflammation. He has published more than 150 book chapters and articles in peer-reviewed journals such as JAMA Dermatology, the New England Journal of Medicine, Journal of the American Academy of Dermatology, and the Journal of Investigative Dermatology, the Journal of the American Medical Association, among others. Dr. Strober also has frequently presented data to the FDA, including at the advisory committee for secukinumab, a novel IL-17 inhibitor for the treatment of psoriasis. He currently is the secretary-treasurer on the Board of the International Psoriasis Council and Co-Scientific Director of the Corrona Psoriasis Registry.

His primary clinical focus is the treatment of difficult-to-treat inflammatory diseases of the skin, such as psoriasis, atopic dermatitis and hidradenitis suppurativa.

Prior to co-founding Central Connecticut Dermatology, Dr. Strober was Professor and Chair in the Department of Dermatology, University of Connecticut School of Medicine in Farmington, Connecticut.